LncRNA DSCAM-AS1 Negatively Interacts with miR-124 to Promote Hepatocellular Carcinoma Proliferation
Zheng Wang1, Shengmian Li2, Gaili Zhang3
1Department of Gastroenterology, Hebei Medical University, Shijiazhuang City, Hebei Province, 050000, P.R. China.
Abstract:
It is known that the development of resistance of breast cancer cells to chemotherapy is at least partially mediated by the upregulation of long non-coding RNA DSCAM antisense RNA 1 (DSCAM-AS1). Therefore, DSCAM-AS1 may play a role in cancer biology. The differential expression of DSCAM-AS1 and miR-124 in hepatocellular carcinoma (HCC) was analyzed by quantitative polymerase chain reaction. One-way analysis of variance (ANOVA) Tukey test was used to analyze the differences in gene expression and cell proliferation in HCC cell lines. Expression levels of DSCAM-AS1 and miR-124 were compared between HCC and paired non-tumor tissues by paired t-test. The effects of transfections on SNU-449 and SNU-398 cell proliferation were analyzed by CCK-8 assay. DSCAM-AS1 was upregulated, while miR-124 was downregulated in HCC tissues. DSCAM-AS1 and miR-124 were inversely correlated across HCC tissues but not normal tissues. DSCAM-AS1 level increased, while miR-124 level decreased along with the clinical stage increasing. miR-124 overexpression increased DSCAM-AS1 level while DSCAM-AS1 overexpression decreased miR-124 level. In addition, miR-124 overexpression decreased HCC cell proliferation, while DSCAM-AS1 increased HCC cell proliferation. Moreover, DSCAM-AS1 overexpression reduced the effects of miR-124 overexpression. DSCAM-AS1 interacts with miR-124 to promote HCC proliferation.
Insights
Long non-coding RNA DSCAM antisense RNA 1 (DSCAM-AS1) promotes hepatocellular carcinoma (HCC) proliferation by interacting with miR-124. This study reveals DSCAM-AS1 as a potential therapeutic target for HCC, as its upregulation correlates with disease progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNA DSCAM antisense RNA 1 (DSCAM-AS1) is implicated in chemotherapy resistance in breast cancer.
- Understanding the role of DSCAM-AS1 in other cancers, like hepatocellular carcinoma (HCC), is crucial.
Purpose of the Study:
- To investigate the differential expression and functional role of DSCAM-AS1 and miR-124 in HCC.
- To explore the interaction between DSCAM-AS1 and miR-124 in HCC progression.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) for gene expression analysis.
- Paired t-test and ANOVA Tukey test for statistical comparisons.
- CCK-8 assay to assess cell proliferation after transfections.
Main Results:
- DSCAM-AS1 was upregulated and miR-124 was downregulated in HCC tissues compared to non-tumor tissues.
- DSCAM-AS1 and miR-124 showed an inverse correlation in HCC tissues, with levels changing with clinical stage.
- DSCAM-AS1 overexpression promoted HCC cell proliferation, while miR-124 overexpression inhibited it. DSCAM-AS1 counteracted miR-124's effects.
Conclusions:
- DSCAM-AS1 promotes HCC proliferation and is inversely correlated with miR-124.
- The DSCAM-AS1/miR-124 interaction plays a significant role in HCC development and progression.
- DSCAM-AS1 represents a potential therapeutic target for hepatocellular carcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs


